We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > DMD

News List

Promising therapeutic approach for improving mitochondrial function europeanpharmaceuticalreview
August 10, 2017
Scientists have made progress in the development of products that improve mitochondrial function…
Breakthrough gene therapy shows promise in Duchenne muscular dystrophy pharmafile
July 27, 2017
New research, led by teams from AFM-Telethon laboratory in Nantes and the University of London,
DMD patients in the UK win early access to Santhera’s Raxone pharmatimes
June 23, 2017
Santhera Pharmaceuticals’ Raxone has become the first drug for Duchenne Muscular Dystrophy (DMD) to join the UK’s Early Access to Medicines Scheme (EAMS).
PTC Therapeutics to Acquire Emflaza™ for the Treatment of Duchenne Muscular Dystrophy in U.S. americanpharmaceuticalreview
March 17, 2017
PTC Therapeutics has entered into an asset purchase agreement with Marathon Pharmaceuticals, LLC to acquire all rights to Emflaza™ (deflazacort).

Previous page 1 2 3 Next page